Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys)

被引：2

作者：

Cha, Yun-Ji ^{[1
]}

Jeon, Sae-Bom ^{[1
]}

Oh, Jaewon ^{[3
]}

Lee, Seung-Tae ^{[4
]}

Kim, Sangwoo ^{[8
,9
]}

Kim, Hyoeun ^{[1
]}

Choi, Jungyoon ^{[1
]}

Choi, Hyo-Kyoung ^{[5
]}

Won, Dongju ^{[4
]}

Choi, Jong Rak ^{[4
]}

Kim, Seok-Jun ^{[6
,7
]}

Park, Sahng Wook ^{[1
,2
]}

Kang, Seok-Min ^{[3
]}

Lee, Seung-Hyun ^{[1
,2
]}

机构：

[1] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[2] Yonsei Univ, Grad Sch Med Sci, Dept Biochem & Mol Biol, Coll Med,Brain Korea 21 Project, 50-1 Yonsei Ro, Seoul 03722, South Korea

[3] Yonsei Univ, Severance Cardiovasc Hosp, Cardiovasc Res Inst, Div Cardiol,Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[4] Yonsei Univ, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[5] Korea Food Res Inst, Res Grp Healthcare, Wanju Gun 55365, Jeollabuk Do, South Korea

[6] Chosun Univ, Dept Biomed Sci, Dept Integrat Biol Sci, Gwangju 61452, South Korea

[7] Chosun Univ, BK21 FOUR Educ Res Grp Age Associated Disorder Co, Gwangju 61452, South Korea

[8] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, 50-1 Yonsei Ro, Seoul 03722, South Korea

[9] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea

来源：

STEM CELL RESEARCH | 2022年 / 60卷

基金：

新加坡国家研究基金会;

关键词：

ALPHA-TROPOMYOSIN MUTATION;

D O I：

10.1016/j.scr.2022.102707

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Dilated cardiomyopathy (DCM) is one of the leading causes of heart transplantation. The clinical feature of DCM is characterized by enlarged heart and impaired function of the left or both ventricles, while its etiology is varied. In this study, we generated YCMi005-A, a human-induced pluripotent stem cell (hiPSC) line from a patient with DCM carrying the missense mutation of p.Glu192Lys in the TPM1 genes. YCMi005-A, an established hiPSC, showed the normal karyotype (46, XX) and high expression of pluripotency markers. In addition, it was confirmed that YCMi005-A has the differentiation potential assessed by staining of three germ layer markers.

引用

页数：5

共 50 条

[31] Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation
Merkert, Sylvia
Schubert, Madline
Haase, Alexandra
Janssens, Hettie M.
Scholte, Bob
Lachmann, Nico
Goehring, Gudrun
Martin, Ulrich
STEM CELL RESEARCH, 2020, 44
[32] Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50
Ermon, Benedetta
Volpato, Claudia B.
Cattelan, Giada
Silipigni, Rosamaria
Di Segni, Marina
Cantaloni, Chiara
Casella, Michela
Pramstaller, Peter P.
Pompilio, Giulio
Sommariva, Elena
Meraviglia, Viviana
Rossini, Alessandra
STEM CELL RESEARCH, 2018, 32 : 78 - 82
[33] Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene
Yan, Rui
Liu, Pengyu
Li, Fake
Chu, Meng
Lei, Jiafan
Wang, Feng
Luo, Liangping
Xu, Xueqing
STEM CELL RESEARCH, 2020, 49
[34] Generation of a human induced pluripotent stem cell line (FSMi001-A) from fibroblasts of a patient carrying heterozygous mutation in the REEP1 gene
Baggiani, Matteo
Santorelli, Filippo Maria
Mero, Serena
Privitera, Flavia
Damiani, Devid
Tessa, Alessandra
STEM CELL RESEARCH, 2024, 79
[35] Generation of an Induced Pluripotent Stem Cell Line ICGi046-A of a Patient Carrying Pathogenic p.Ser259Thr Variant in RAF1 Associated with RASopathy
E. V. Dementyeva
E. S. Klimenko
J. M. Minina
S. M. Zakian
A. A. Kostareva
Russian Journal of Developmental Biology, 2023, 54 : S75 - S81
[36] Generation of an Induced Pluripotent Stem Cell Line ICGi046-A of a Patient Carrying Pathogenic p.Ser259Thr Variant in RAF1 Associated with RASopathy
Dementyeva, E. V.
Klimenko, E. S.
Minina, J. M.
Zakian, S. M.
Kostareva, A. A.
RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY, 2023, 54 (SUPPL 1) : S75 - S81
[37] Generation of an induced pluripotent stem cell line (UCLi026-A) from a patient with ADCY5-related disease carrying the heterozygous variant c.1253G > A; (p. Arg418Gln)
Alhaque, Sharmin
Budinger, Dimitri
Garavaglia, Barbara
Zorzi, Giovanna
Barral, Serena
Kurian, Manju A.
STEM CELL RESEARCH, 2025, 84
[38] Establishment of a human induced pluripotent stem cell line (CSUASOi005-A), from peripheral blood mononuclear cells of a patient with X-linked juvenile retinoschisis carrying a novel mutation in RS1 gene
Mao, Shengru
Ding, Chengcheng
Zhou, Yalan
Jing, Yutong
Chen, Juan
Guo, Yonglong
Liu, Jian
Cui, Zekai
Yan, Xin
Gu, Jianing
Wang, Yini
Chen, Jiansu
Tang, Shibo
STEM CELL RESEARCH, 2020, 43
[39] Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation
Wang Xiaojing
Ma Yanyan
Duan Ruonan
Liu Xiaolin
Zhang Haiyan
Ma Jian
Liu Yi
Sun Wenjie
Liu Qiji
STEM CELL RESEARCH, 2020, 43
[40] Generation of an induced pluripotent stem cell line ICGi030-A from a Wilson's disease patient carrying a frameshift mutation p.Lys1013fs and missense mutation p.H1069Q in the ATP7B gene
Zhigalina, D., I
Malakhova, A. A.
Vasilyeva, O. Yu
Grigor'eva, E., V
Sivtsev, A. A.
Kolesnikov, N. A.
Lopatkina, M. E.
Savchenko, R. R.
Zhalsanova, I. Zh
Postrigan', A. E.
Zarubin, A. A.
Nikitina, T., V
Bueverov, A. O.
Bogomolov, P. O.
Zakian, S. M.
Skryabin, N. A.
STEM CELL RESEARCH, 2021, 57

← 1 2 3 4 5 →